Control Bionics (ASX:CBL) Beginning Cash Position: A$0.60 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Control Bionics Beginning Cash Position?

Control Bionics ASX:CBL -1.33% Beginning Cash Position is A$0.60 Mil as of Dec. 2025. The stock has 4 warning signs investors should review.

Control Bionics's Beginning Cash Position for the quarter that ended in Dec. 2025 was A$0.60 Mil.

Control Bionics's quarterly Beginning Cash Position declined from Dec. 2024 (A$0.98 Mil) to Jun. 2025 (A$0.97 Mil) and declined from Jun. 2025 (A$0.97 Mil) to Dec. 2025 (A$0.60 Mil).

Control Bionics's annual Beginning Cash Position declined from Jun. 2023 (A$5.22 Mil) to Jun. 2024 (A$0.94 Mil) but then increased from Jun. 2024 (A$0.94 Mil) to Jun. 2025 (A$0.98 Mil).

Control Bionics Beginning Cash Position Related Terms

Control Bionics Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Control Bionics's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Control Bionics Beginning Cash Position Chart

Control Bionics Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Beginning Cash Position
Get a 7-Day Free Trial 1.43 12.33 5.22 0.94 0.98

Control Bionics Semi-Annual Data
Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.94 1.31 0.98 0.97 0.60

Control Bionics Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of A$0.60 Mil mean?
Control Bionics (ASX:CBL) has a Beginning Cash Position of A$0.60 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Control Bionics and its competitors.
Is Control Bionics' Beginning Cash Position too high?
Control Bionics' current Beginning Cash Position is A$0.60 Mil.
How does Control Bionics' Beginning Cash Position compare to ABT and SYK?
Control Bionics' Beginning Cash Position of A$0.60 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Medical Devices & Instruments company?
A good Beginning Cash Position depends on the Medical Devices & Instruments industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Control Bionics and its competitors. Control Bionics's current Beginning Cash Position is A$0.60 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Control Bionics stock overvalued right now?
Based on GuruFocus' analysis, Control Bionics (ASX:CBL) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.03, compared to a current price of A$0.07 — trading 146.7% above its estimated fair value. The current Beginning Cash Position is A$0.60 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Control Bionics (ASX:CBL), the current Beginning Cash Position is A$0.60 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Control Bionics Business Description

Address 11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically, it derives a majority of revenue from North America and has its presence in Australia as well.